Clinical Trials

Can Augmented Reality Give Doctors Real-Time X-Ray Vision?
Tech & Innovation Can Augmented Reality Give Doctors Real-Time X-Ray Vision?

The traditional process of interpreting medical ultrasound images often feels like solving a complex puzzle where clinicians must transform flat two-dimensional slices into a coherent three-dimensional model of the human body. This cognitive transformation, often referred to as mental tomography,

Could Cell Therapy Be the Cure for Type 1 Diabetes?
Management & Regulatory Could Cell Therapy Be the Cure for Type 1 Diabetes?

Living with Type 1 diabetes has historically meant a lifetime of constant surveillance, where every meal and physical activity requires a calculated response to maintain a delicate biological balance. For nearly a century, the medical standard of care focused almost exclusively on external

DNA Hydrogel Breakthrough Accelerates Complex Bone Healing
Research & Development DNA Hydrogel Breakthrough Accelerates Complex Bone Healing

Surgeons have long struggled with the intricate biological demands of repairing massive skeletal defects where traditional bone grafts often fail due to poor integration or limited availability of donor tissue. In the current landscape of regenerative medicine, the pursuit of a biocompatible

Can AI Chatbots Outperform Traditional HPV Health Messaging?
Tech & Innovation Can AI Chatbots Outperform Traditional HPV Health Messaging?

The human papillomavirus remains a pervasive health threat that accounts for thousands of preventable cases of cervical, anal, and oropharyngeal cancers annually, yet vaccination rates frequently stall below target goals despite the shot's proven efficacy. This persistent challenge has driven

Will Takeda’s Zasocitinib Redefine Oral Psoriasis Treatment?
Research & Development Will Takeda’s Zasocitinib Redefine Oral Psoriasis Treatment?

The landscape of autoimmune treatment is currently undergoing a seismic shift as high-potency oral medications begin to rival the long-standing dominance of injectable biologic therapies. Takeda Pharmaceutical Company recently demonstrated that its experimental drug, zasocitinib, could

Can Novartis’ $12B RNA Drug Transform FSHD Treatment?
Research & Development Can Novartis’ $12B RNA Drug Transform FSHD Treatment?

Ivan Kairatov is a seasoned biopharma expert whose career has been defined by a deep immersion in the research and development of next-generation medical technologies. With a focus on how innovation translates from the laboratory to the patient, he has become a leading voice in evaluating the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later